Micreos ‘Alternative to antibiotics’ winner of Ideas from Europe competition
On April 26, 2018, Micreos was chosen as Europe’s most relevant innovation at the finals of the EU’s Ideas from Europe competition. Ideas from Europe is a European initiative that facilitates sustainable innovations aimed at global challenges.
Twelve finalists pitched their inspiring innovations to tackle global challenges, such as healthcare challenges, climate change, immigration, bullying, food waste, extinction of species and renewable energy. Public and policymakers at the Knights Hall then chose their most impactful innovation.
With Micreos’ endolysin technology, it is possible to kill only the unwanted bacteria, regardless of antibiotic resistance. Contrary to existing antibiotics it leaves the beneficial bacteria - essential for our health – intact, preserving the microbiome.
Micreos CEO Mark Offerhaus: “Antibiotic-resistance is an enormous global problem. We've already been able to help over 50.000 people suffering from inflammatory skin diseases such as eczema, acne and rosacea, and wound infections caused by the Staphylococcus aureus bacteria, including the resistant MRSA, but millions can and should benefit. Patients and policymakers need to take their responsibility. There is no need to wait and there is no time to lose."
Watch Finals pitch by Micreos CEO Mark Offerhaus:
Ideas from Europe
Ideas from Europe is a European platform aimed at promoting the development of ideas for society's major challenges. The concept behind Ideas from Europe is that the involvement of the public at large can propel relevant breakthrough innovation (www.ideasfrom.eu).